Pacific Biosciences of California

Healthcare · Medical Devices

2.70$ +0.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Pacific Biosciences of California (PACB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 752 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PACB
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,898	1,746	1,670	1,509	1,450	1,260	861	825	803	784	782	752
Current Assets	882	742	677	628	584	496	445	413	394	375	370	339
Cash	386	180	77	100	78	55	59	55	56	64	56	61
Cash & Short-Term Investments	768	632	562	510	471	390	343	315	299	280	276	237
Receivables	30	37	30	32	29	28	32	32	31	35	29	31
Inventory	68	57	67	69	66	59	54	54	53	49	51	61
Goodwill	464	462	462	369	369	318	318	318	318	318	318	318
Intangible Assets	462	457	450	443	436	390	18	17	16	15	14	13
Total Liabilities	1,135	1,045	1,021	1,017	997	754	769	764	767	779	780	785
Current Liabilities	184	95	73	78	60	66	67	60	63	54	65	69
Short-Term Debt	9.5	10	9.8	12	11	10	2.4	0.7	3.6	0.4	0.3	1.4
Accounts Payable	16	15	21	17	12	17	14	15	16	21	14	19
Long-Term Debt	892	892	893	893	893	647	646	646	645	645	644	644
Shareholders' Equity	764	701	649	493	453	507	92	61	36	5.3	2.4	-33
Retained Earnings	-1,757	-1,839	-1,917	-2,091	-2,151	-2,149	-2,575	-2,617	-2,655	-2,695	-2,704	-2,748
Shares Outstanding	255	267	270	272	273	307	297	300	301	302	306	311

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings